Analyzing...
Loading company...
No significant concerns identified
Nothing flagged for monitoring
“Operates in Healthcare — Equipment & Devices.”
₹63 Cr revenue.
COGS 19.4%, employees 18.0%.
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 17.2%▲ | 12.3% |
| ROCE | 22.8%▲ | 15.3% |
| Net Margin | 27.1%▲ | 8.5% |
| EBITDA Margin | 39.0%▲ | 14.9% |
| Debt To Equity | 0.00x▼ | 0.10x |
Historical valuation data not available.
| (₹ Cr) | FY2025 | FY2024 |
|---|---|---|
| Revenue | ₹63 Cr +11.7% | ₹56 Cr |
| Other Income | ₹4 Cr +42.1% | ₹3 Cr |
| Total Income | ₹67 Cr +13.2% | ₹59 Cr |
| COGS | ₹12 Cr -9.6% | ₹14 Cr |
| ₹43 Cr +13.2% | ₹38 Cr | |
| Profit Before Tax | ₹24 Cr +13.1% | ₹21 Cr |
| ₹6 Cr +15.1% | ₹5 Cr | |
| Net Profit | ₹18 Cr +12.5% | ₹16 Cr |
| Profit (Owners) | ₹18 Cr +12.5% | ₹16 Cr |
| EPS | ₹15.13 | ₹13.44 |
| Diluted Shares | ₹1 Cr | ₹1 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
Non-Applicability of Annual Secretarial Compliance Report for the Financial year ended March 31, 2026
Cessation of Mr. Pardeep Gandotra as Independent Director of the Company due to completion of tenure.
Intimation of Closure of Trading Window
Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve the unaudited Financial Results .... Preves...
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018
Intimation of Closure of Trading Window.
Transcipt of the Company''s Earning call held on November 20, 2025.
Please find enclosed the audio recording of the Company's Earnings Call held with Investors/Analysts on November 20, 2025, to discuss the financial performance of the Company for the half .... Please ...
Intimation of Revised Schedule of Analyst / Institutional Investor Earnings Call under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation regarding postponement of Analyst/ Institutional Investor Earnings Call due to unforeseen work exigencies.
Investor Presentation to be made to Analysts/Investors
Earnings Discussion is scheduled to be held on, Monday, 17th November 2025 at 4.00 PM.
Unaudited Financial results of the Company for the quarter ended September 30, 2025
Outcome of the Board Meeting held on Wednesday, November 12, 2025 pursuant to Regulations 30, 33 and other applicable Regulations of the SEBI (Listing Obligations and Disclosure Requirements) .... Out...
Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve the unaudited financial results .... Preves...
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.